Literature DB >> 10646847

Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding.

N B Adey1, L Huang, P A Ormonde, M L Baumgard, R Pero, D V Byreddy, S V Tavtigian, P L Bartel.   

Abstract

Two-hybrid searches with the tumor suppressor MMAC1/PTEN isolated the proteins hDLG and hMAST205. Further two-hybrid analysis and microtiter plate binding assays localized the sites of interaction to PDZ domains from hDLG and hMAST205 and the PDZ binding domain at the COOH terminus of MMAC1/PTEN. A synthetic peptide derived from the MMAC1/PTEN PDZ binding domain (MMAC1/PTEN-PDZBD) was used to coprecipitate proteins from A431 human cell lysate. The recovered proteins were resolved by SDS-PAGE and immobilized on a nitrocellulose membrane. Treatment of this membrane with an anti-hDLG antibody identified a Mr 140,000 band, consistent with the size of hDLG. Treatment of this membrane with the MMAC1/PTEN-PDZBD peptide identified a single prominent band of slightly larger than Mr 200,000 (Mr 200,000 kDa). Threonine phosphorylation of the MMAC1/ PTEN-PDZBD peptide inhibited both microtiter plate binding to the hDLG and hMAST205 PDZ domains and coprecipitation of the Mr 140,000 and > 200,000 proteins, but promoted coprecipitation of proteins of approximately Mr 90,000 and Mr 120,000 from A431 cell lysate. This result suggests phosphorylation of the MMAC1/PTEN PDZ binding domain can both inhibit and promote PDZ interactions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10646847

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  58 in total

1.  PTEN controls tumor-induced angiogenesis.

Authors:  S Wen; J Stolarov; M P Myers; J D Su; M H Wigler; N K Tonks; D L Durden
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Membrane-binding and activation mechanism of PTEN.

Authors:  Sudipto Das; Jack E Dixon; Wonhwa Cho
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

3.  Scaffold protein Disc large homolog 1 is required for T-cell receptor-induced activation of regulatory T-cell function.

Authors:  Alexandra Zanin-Zhorov; Jiqiang Lin; Jose Scher; Sudha Kumari; David Blair; Keli L Hippen; Bruce R Blazar; Steven B Abramson; Juan J Lafaille; Michael L Dustin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

4.  Coexpression of MAST205 inhibits the activity of Na+/H+ exchanger NHE3.

Authors:  Dongsheng Wang; Hye Jeong Lee; Deborah S Cooper; Ludmila Cebotaro; Paul D Walden; Inyeong Choi; C Chris Yun
Journal:  Am J Physiol Renal Physiol       Date:  2005-09-13

5.  Cell cycle arrest and apoptosis by expression of a novel TPIP (TPIP-C2) cDNA encoding a C2-domain in HEK-293 cells.

Authors:  Rasmi Rekha Mishra; Jitendra Kumar Chaudhary; Pramod C Rath
Journal:  Mol Biol Rep       Date:  2012-02-07       Impact factor: 2.316

6.  Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.

Authors:  N R Leslie; D Bennett; A Gray; I Pass; K Hoang-Xuan; C P Downes
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

Review 7.  PTEN function: the long and the short of it.

Authors:  Benjamin D Hopkins; Cindy Hodakoski; Douglas Barrows; Sarah M Mense; Ramon E Parsons
Journal:  Trends Biochem Sci       Date:  2014-03-18       Impact factor: 13.807

Review 8.  Protein complexes that control renal epithelial polarity.

Authors:  Jay Pieczynski; Ben Margolis
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-12

9.  Retinal degeneration triggered by inactivation of PTEN in the retinal pigment epithelium.

Authors:  Jin Woo Kim; Kyung Hwa Kang; Patrick Burrola; Tak W Mak; Greg Lemke
Journal:  Genes Dev       Date:  2008-11-07       Impact factor: 11.361

10.  PDZ domains and their binding partners: structure, specificity, and modification.

Authors:  Ho-Jin Lee; Jie J Zheng
Journal:  Cell Commun Signal       Date:  2010-05-28       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.